COVID Vaccine Initiative

The COVID Vaccine Initiative (CVI) aims to ensure the development of safe, effective, and accessible vaccines for those most vulnerable to COVID-19: aging populations and those living in low- and middle-income countries. It leverages HVP’s global clinical research consortium, including newly established collaborations with the Harvard T.H. Chan School of Public Health focused on deciphering effective immunity in aging populations; FHI 360, a global nonprofit research and human development organization with extensive experience working in low and middle-income countries; and the University of Minnesota’s Center for Infectious Disease Research and Policy, a global leader in addressing public health preparedness and emerging infectious disease response.

COVID Newsroom

Global COVID Lab Meeting

Aug 13, 2020

Dan Barouch

Harvard, Beth Israel Deaconess Medical Center

Global COVID Lab Meeting

Jul 30, 2020

Galit Alter

Ragon Institute of MGH, MIT and Harvard

Global COVID Lab Meeting

Jul 16, 2020

Joseph Jardine and Thomas Rogers

The Scripps Research Institute

Global COVID Lab Meeting

Jul 02, 2020

Shane Crotty

La Jolla Institute for Immunology

Global COVID Lab Meeting

Eleanor Fish

University of Toronto